GlassScriptPhysician profile
Alice Mendelson
NPI 1104816081
$4,931.21
in general payments reported to CMS, 2019-2025
25 companies · $204 in 2025
The $204 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $493 · 2020: $117 · 2021: $231 · 2022: $291 · 2023: $89.67 · 2024: $3,506 · 2025: $204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,424 · Food and Beverage: $1,376.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,423.79 |
| Food and Beverage | $1,376.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $3,327.15 | 2024-2025 | Rosa, Persona, Tapestry |
| Amgen INC. | $499.60 | 2019-2025 | Evenity, Prolia, Prolia |
| Nuvasive Specialized Orthopedics, INC. | $189.19 | 2019 | |
| Bioness INC | $137.46 | 2021 | |
| Janssen Biotech, INC. | $133.61 | 2019-2022 | |
| Abbvie INC. | $96.17 | 2019-2022 | |
| Stryker Corporation | $67.37 | 2020-2024 | T2 Alpha, Gamma |
| Ferring Pharmaceuticals INC. | $62.76 | 2019-2025 | Euflexxa |
| Medtronic, INC. | $51.81 | 2025 | Synchromedii |
| Vertex Pharmaceuticals Incorporated | $50.74 | 2024-2025 | |
| Radius Health, INC. | $43.91 | 2019-2022 | |
| Bioventus LLC | $41.50 | 2022-2023 | Durolane |
| Treace Medical Concepts, INC. | $28.38 | 2025 | |
| Alvogen INC | $27.74 | 2022 | |
| Convatec INC. | $27.60 | 2019-2023 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle, INC | $22.39 | 2025 | |
| Alexion Pharmaceuticals, INC. | $17.98 | 2022 | |
| Kci USA, INC. | $16.60 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $15.50 | 2022 | |
| Horizon Therapeutics Plc | $14.05 | 2020 | |
| Depuy Synthes Sales INC. | $14.03 | 2024 | Monovisc, Orthovisc |
| Fidia Pharma USA INC. | $13.60 | 2023 | Triluron, Hymovis |
| Sanofi-Aventis U.S. LLC | $11.82 | 2022 | |
| Ethicon US, LLC | $11.36 | 2019 | |
| Heron Therapeutics, INC. | $8.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alice Mendelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.